Skip to main content
. Author manuscript; available in PMC: 2019 May 3.
Published in final edited form as: Mol Cell. 2018 Apr 26;70(3):516–530.e6. doi: 10.1016/j.molcel.2018.03.026

Figure 3. Functional MRH-domain in OS9 and XTP3B is required for ERAD of glycosylated substrates.

Figure 3

(A and B) PSI-chase analysis of endogenous CD147 and HLA-C in WT, DKO, and DKO cells stably expressing the indicated OS9 (A) or XTP3B (B) variants. Quantification represents mean±SEM (n=3). Independent immunoblots are indicated by the dashed horizontal lines. See also Fig. S3.